Methods Patients. Since January 1998, 35 patients have undergone percutaneous PFO
closure. In all cases, patient history included a thromboembolic event attributed to …

Background: Percutaneous patent foramen ovale (PFO) closure seems to reduce the risk of
recurrent thromboembolism. We report the safety and efficacy of percutaneous PFO closure …

Background Paradoxical embolism due to the presence of patent foramen ovale (PFO) is a
well-established possible mechanism of ischaemic stroke of unknown origin. Mechanical …

The role of patent foramen ovale (PFO) in patients with cryptogenic stroke (stroke of
unknown cause) remains controversial, although an association seems likely in younger …

Objectives: The present study was conducted to determine the safety of the transcatheter
closure of a patent foramen ovale (PFO) in patients with cryptogenic cerebral ischemia and …

Introduction—Patent foramen ovale (PFO) has been identified as a source of paradoxical
embolism and cryptogenic stroke. Low recurrence rates of ischaemic stroke after …

ABSTRACT A patent foramen ovale (PFO) enables a right-to-left shunt in about a quarter of
the population. The marked association between cryptogenic stroke and PFO supports the …

Objectives: The purpose of this study was to compare the efficacy of medical treatment with
percutaneous closure of patent foramen ovale (PFO). Background: Patients with cryptogenic …

Objectives: To carry out long-term follow-up after percutaneous closure of patent foramen
ovale (PFO) in patients with cryptogenic stroke. Design: Prospective cohort study. Setting …

OBJECTIVE: To report our data on selected patients with previous paradoxical embolism
who underwent transcatheter patent foramen ovale (PFO) closure. METHODS: Between July …